Table Of Content

Antiviral Chemistry & Chemotherapy (1992) 3(6), 379-380 Subject index (compiled using key words) absorption 1, 65 distribution 1, 65 actinomycin D 361 DNA gyrase inhibitors 183 acyclovir 1, 157 DNA polymerase 223 adenosine deaminase 179 DNA polymerase 243 African swine fever virus 9 drug synthesis 79 2-aminopurine 153 amino ester prodrugs 157 elimination 1, 65 animal model 267 ELISA 55 anionic 9 encephalitis 37 antagonism 85 envelope hlycoproteins 55 antibiotic quartromicin 345 enzymatic synthesis 153 antibody to GOR epitope 305 enzyme assay 113 antibody to hepatitis C virus 305 5’-ester prodrugs 141 antiviral 327, 335, 361 Evans blue 49 antiviral activity 15, 95, 107, 153 antiviral agent 141 famciclovir 37 antiviral agents 37 feline leukaemia virus 335 antiviral chemotherapy 263 feline virus 249 antiviral chemotherapy in veterinary medicine 249 3’-fluorothymidine 267 antiviral compounds 147, 203 3’-fluoro-3’-deoxythymidine 165 antiviral peptides 31 antiviral testing 79 ganciclovir 327 antiviral therapy 127, 267 Glucosidase 1, 273 anti-HIV compounds 345 gp120 147 anti-rhinovirus activity 195 gP120 binding 49 Anti-VZV drugs 293 araA 79 haemotopoiesis 179 araC 79 haloalkyl phosphate triester derivatives 79 aurintricarboxylic acid 49 hepatitis C virus RNA 305 aurintricarboxylic acid (ATA) 215 herpes simplex virus 85, 215, 243 3'-azido-2' ,3'-dideoxythymidine (AZT) 345 herpes simplex virus type 1, 95 3’-azido-3’deoxythymidine 165 herpes simplex virus type 1 (HSV-1) 15, 157 azido-thymidine 85 herpesvirus 293 AZT 189, 299 HIV 107, 113, 121, 147, 273, 351 HIV-1 55, 223, 263 9-B-D-2’,3’-dideoxynucleosides 153 HIV-2 263 9-B-D-2'-deoxy 153 HIV-inhibitors 189 biotransformation 179 HIV/AIDS 203 HSV 293, 351 carbocyclic riucleoside 121 HSV-1 37, 223 carbovir 121 HTLV-1 11, 127 carrier bound template/primers 203 human immunodeficiency virus 23, 153, 165, 279, 299, 345 castanospermine 23 human immunodeficiency virus type 1, 183 Cat 335 human lymphoblastoid interferon 305 CD4 147 human T-cell lymphotropic viruses 127 CD4 antigen 49 chronic hepatitis C 305 immunosuppression 327 CMV 351 in vitro toxicity 179 combination chemotherapy 165 influenza virus 171 combination therapy 183 inhibition 279 coumermycin Al 183 inhibitors 9, 273 cytomegalovirus 215, 327 integrase 113 interferon 85, 351 2’,3’-dideoxy-3’-thiacytidine 299 interferon alpha 183 deoxynucleoside triphosphates 165 interferon therapy 305 dextran sulphate 351 isoflavans 195 dideoxynucleosides 299 2(2H)-isoflavenes 195 380 Subject index leukaemia virus 283 retroviruses 351 lymphoblastoid cells 165 reverse transcriptase 203, 223, 279 L-valyl ester 157 reverse transcriptase inhibitor 345 rhinovirus 361 metabolism 1, 65 RIA 55 methoxymethyideoxycytidine 243 ribavirin 361 methoxymethyldeoxyuridine 243 RT-assays 203 5-methoxymethyl-2'-deoxycytidine 15 RT-inhibitors 203 5-methoxymethyl-N-methyl-2’-deoxycytidine 15 6-methoxypurine arabinoside 141 selenium 263 6-methozypurine arabinoside 371 Sindbis virus 31 mouse 37 SIV 267 species differences 1 NK activity 299 stability 121 nucleoside analogues 79 stereoisomers 273 sulphated polysaccharides 23 parainfluenza virus 171 syncytium formation SCD4 23 penciclovir 37, 85 synergy 85 phenalamide A21 189 S-alkynyl pyrmidine nucleosides 293 phenoxan 189 phospholipase-C 283 3TC 299 phosphonoformate 335 tetrachloro decaoxide 95 phosphonoformate 107 thiangazole 189 phosphorodiamidate derivatives 107 three-dimensional modelling 223 phosphorylation 165 topoisomerase inhibitors 183 picornavirus 361 trans-acting factor 283 poliovirus 361 Polyacetal polysulphate 351 ULV 107 polyanionic compounds 23 polycarboxylates 215 varicella-zoster virus 141, 371 porphyrin 55, 279 vesicular stomatitis virus 31 prodrugs 371 virus absorption 215 purine arabinosides 179 virus assembly viral hlycoprotein 31 purine nucleoside phosphorylase 121 virus replication 179 pyridobenzimidazoles 171 VSV 293, 351 pyridobenzoazoles 171 Pyrrolizidines 273 xanthate 283 respiratory syncytial virus (RSV) 171 zidovudine 65, 107 retrovirus 327, 335 Antiviral Chemistry & Chemotherapy (1992) 3(6), 381-382 Author index Adams, S.P. 31 Haberfield, P. 55 Murakami, T. 345 Aduma, P.J. 15, 243 Harvey, J.J. 107 Murray, B.K. 361 Akazawa, K. 305 Hay, A.J. 153 Music, L. 283 Anand, R. 147 Hayashi, J. 305 Andersen, D.O. 361 Hayes, K.A. 335 Nagode, L.A. 335 Andrei, G. 351 Helbig, B. 215 Nakashima, H. 305, 345 Arnout, J. 351 Hicks, N. 153 Nash, R. 273 Aszalos, A. 147 Hirata, M. 305 Neumuller, M. 203 Avereett, D.R. 179 Hofle, G. 189 Neurath, A.R. 55 Hopfinger, A.J. 125 Neyts, J. 215 Baba, M. 125, 171 Hosoya, M. 171 Noble, R.L. 327 Bacon, T.H. 85 Huffman, J.H. 327 Noguchi,A . 305 Beauchamp, L.M. 157 Hunsmann, G. 1889 North, J.A. 361 Hutchinson, D.W. 153 Bell, S. 147 Billich,A . 113 Oberg, B. 267 Ideda, S. 351 Billich, S. 113 Oki, T. 345 Birch, C. 183 Okleberry, K.M. 327 Bottiger, D. 267 Jansen, R. 189 Orr, G.F. 157 Boyd, M.R. 37, 85 Jardine, D. 183 Orsi, N. 195 Jeffries, D.J. 107 Burger, R.A. 327 O’Connor, T.J. 107 Jia, Z. 15 Burnette, T. 157 Jiang, S. 55 Johansson, M. 203 Palker, T.J. 127 Cattini, L. 299 Jones, B.C.N.M. 79, 107 Pauwels, R. 23, 351 Chamberlain, S.D. 141, 371 Jones, L.A. 141, 371 Pease, A. 327 Chiba, T. 171 Jurkiewicz, E. 189 Penn, C.R. 121 Claes, P. 351 Peoples, M.E. 144 Collier, N.C. 31 Kallander, C.F.R. 203 Petterson, A. 203 Collins, P. 293 Kang, M.S. 273 Polas, P.J. 335 Conti, C. 195 Kashiwagi, S. 305 Powell, K.L. 293 Cox, S. 165 Kinchington, D. 107 Purifoy, D.J.M. 293 Cushman, M. 215 Klécking, R. 215 Rahim, S.G. 293 Reichenbach, H. 189 Kociba, G.L. 335 Darby, G. 293 Koszalka, G.W. 179, 371 Reynolds, D.J. 141, 371 Dargan, D.J. 95 Kozlowski, M.R. 49 Riley, P.A. 79 De Clercq, E. 23, 171, 215, 351 Krenitsky, A. 141 Robins, R.K. 361 Rollinson, E.A. 249, 311 de Miranda, P. 165, 141, 157, 371 Krenitsky, T.A. 157, 179, 371 Degrassi,A . 299 Kumar, V.P.S. 15 Rosenwirth, B. 113 Delbaere, L.T.J. 15 Kunze, B. 189 Desideri, N. 195 Sauer, G. 283 Desmyter,J . 23, 351 Lennerstrand,J . 203 Schauer, M. 113 Devine, K.G. 107 Lindborg, B. 223 Schinazi, R.F. 263 Lisignoli, G. 299 Schlesinger, M.J. 31 Locarnini, S. 183 Schols, D. 23, 351 Facchini, A. 299 Scott Pine, P. 147 Fellows, L.E. 273 Mahmood, N. 153 Selway,J . 293 Field, H.J. 37 Mariani, E. 299 Sestili, |. 195 Forche, E. 189 Marr, C.L.P. 121 Shigeta, S. 171 Framk, S. 113 Mathes, L.E. 335 Sidwell, R.W. 327 McCuigan, C. 79, 107 Smee, D.F. 327 Garcia-Villalon, D. 9 McMillan, A. 263 Snoeck, R. 215, 351 Gil-Fernandez, C. 9 Mochizuki, N. 171 Spector, T. 179 Goldthorpe, S.E. 37 Mohan, P. 125 Stein, M.L. 195 Good, S.S. 1, 65 Monaco, M.C. 299 Steinberg, H.N. 179 Goudgaon, N.M. 263 Moorman, A.R. 141, 371 Strick, N. 55 Gronowitz, J.S. 203 Mori, S. 171 Stuart, A.L. 15, 243 Gupta, S.V. 15, 243 Morrey, J.D. 327 Subak-Sharpe, J.H. 95 382 Author index Sutton, D. 85 Tomao, P. 195 Wang, Y. 215 Swenson, C.L. 335 Tourigny, G. 15 Watson,A . 49 Trevidi, N. 293 Weaver, J.L. 147 Tachedjian, G. 183 Trowitzsch-Kienast, W. 189 Weingarten, H. 31 Tanabe-Tochikura, A. 345 Tyms, A.S. 273 Weisbrode, S.E. 335 Taylor, D.L. 83, 273 Tyssen, D. 183 Witrouw, M. 23, 351 Taylor-Robinson, D. 107 Wutzler, P. 215 Tenmyo, O. 345 Van Schepdael, A. 351 Tollerfield, S.M. 79 Vrang, L. 267 Yamamoto, N. 345